Previous 10 | Next 10 |
Cancer Research Horizons is the innovation arm of Cancer Research UK Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Cancer Research Horizons , the innovation en...
-- TB-222-023 Discovered and Optimized Using Twist’s Synthetic DNA Libraries and Antibody Engineering Services -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, ...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Chet Gandhi as chief information officer. Mr. Gandhi brings a wealth of experience in leading ...
RNA fusions can be used as biomarkers to identify cancer sub-types and monitor for residual disease Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and CeGaT GmbH , ...
2023-05-30 17:31:44 ET Gainers: Extreme Networks ( EXTR ) +6% . Elevation Oncology ( ELEV ) +6% . Annexon ( ANNX ) +4% . Twist Bioscience Corporation ( TWST ) +4% . Omeros Corporation ( OMER ) +4% . Losers: Ambarella ( ...
2023-05-24 11:27:03 ET Summary Twist's moderate growth and large losses continue to place downward pressure on the stock. Twist is increasing its focus on profitability, but the shift in strategy also raises questions about the growth outlook. If Twist can continue to grow its...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Robert Werner as chief accounting officer. “Rob has a proven track record of leading ...
Includes Twist RNA Exome, target enrichment for RNA and whole transcriptome sequencing Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of a ...
2023-05-19 13:28:28 ET Summary The stock of Twist Bioscience Corporation has declined more than 60% since our first peek at it in the fall of last year. However, the stock saw its first insider buy in a year last week, and the company is restructuring its organization to lower cos...
2023-05-15 12:03:23 ET Twist Bioscience Corporation ( NASDAQ: TWST ) added ~16% on Monday to mark the biggest intraday gain since November after its senior vice president Dennis Cho disclosed the purchase of 10K shares of the synthetic biology company. According to a regul...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...